Analysis of microbial communities in local cultivars of astringent persimmon (Diospyros kaki) fruits grown in Gyeongnam Province of Korea

Choi, Ji-Ho; Choi, Sun-Young; Lee, J.S.; Kang, Shin-Min; Kim, J.I.; Choi, Mansoo; Kim, H.G.; Seo, Weon Taek; Lee, K.Y.; Moon, Byungin; Kang, Younhee; Lee, K.C.

doi:10.22438/jeb/39/2/mrn-450

Cited by 4 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The calyx of Diospyros kaki Thunb. exhibits antimicrobial, anticancer, anti-inflammatory, antioxidant, anticoagulant, antithrombotic, antigenotoxic, diaphragm contraction inhibitory, elastase inhibitory, and tyrosinase inhibitory effects ( Jang et al 2010 ; Park et al 2017 ; Choi et al 201 9 ). In traditional Korean medicine (TKM), the calyx has a mild nature, a bitter and astringent taste, poison-free ( Heo 2001 ) and it is known to release blocked Qi.…”

Section: Introductionmentioning

confidence: 99%

“…In traditional Korean medicine (TKM), the calyx has a mild nature, a bitter and astringent taste, poison-free ( Heo 2001 ) and it is known to release blocked Qi. A number of microorganisms that could become a new valuable source of medicine ( Choi et al 2018 ) also inhabited D. kaki fruit stalk. Based on microbial community analysis, Metschnikowia sp.…”

Section: Introductionmentioning

confidence: 99%

“…Based on microbial community analysis, Metschnikowia sp. are the dominant microorganisms associated with the native varieties of Diospyros kaki fruits cultivated in Gyeongnam Province, Korea ( Choi et al 2018 ). Metschnikowia is one of the most diverse genera of ascomycetous yeasts, consisting of more than 80 identified species isolated from many types of hosts ( Lachance 2016 ).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The whole-genome sequence of the novel yeast species Metschnikowia persimmonesis isolated from medicinal plant Diospyros kaki Thunb

Rahmat

Park

Kang

2021

G3 Genes|Genomes|Genetics

View full text Add to dashboard Cite

The new yeast Metschnikowia persimmonesis KCTC 12991BP (KIOM G15050 strain) exhibits strong antimicrobial activity against some pathogens. This activity may be related to the medicinal profile of secondary metabolites that could be found in the genome of this species. Therefore, to explore its future possibility of producing some beneficial activities, including medicinal ability, we report high quality whole-genome assembly of M. persimmonesis produced by PacBio RSII sequencer. The final draft assembly consisted of 16 scaffolds with GC content of 45.90% and comprised a fairly complete set (82.8%) of BUSCO result using Saccharomycetales lineage data set. The total length of the genome was 16.473 Mb, with a scaffold N50 of 1.982 Mb. Annotation of the M. persimmonesis genome revealed presence of 7,029 genes and 6,939 functionally annotated proteins. Based on the analysis of phylogenetic relationship and the average nucleotide identities (ANI), M. persimmonesis was proved to a novel species within the Metschnikowia genus. This finding is expected to significantly contribute to the discovery of high-value natural products from M. persimmonesis as well as for genome biology and evolution comparative analysis within Metschnikowia species.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The whole-genome sequence of the novel yeast species Metschnikowia persimmonesis isolated from medicinal plant Diospyros kaki Thunb

Rahmat

Park

Kang

2021

G3 Genes|Genomes|Genetics

View full text Add to dashboard Cite

show abstract

Yeast metabolic engineering for the production of pharmaceutically important secondary metabolites

Rahmat

Kang

2020

Appl Microbiol Biotechnol

View full text Add to dashboard Cite

Unforeseen current and future benefits of uncommon yeast: the Metschnikowia genus

Haniffadli,

Ban,

Rahmat

et al. 2024

Appl Microbiol Biotechnol

View full text Add to dashboard Cite

Metschnikowia, the single-cell yeast form, is a genus of 85 species in the Saccharomycetales order that developed in both aquatic and terrestrial ecosystems after being found in 1899. This yeast is commonly used to control microbial populations in many biological and artificial conditions, such as fermentation. However, current study of Metschnikowia is limited to biological control features rather than researching on lucrative sectors such as beverage production, bioconversion manufacturing, cosmetics, and the pharmaceutical industry. This review summarizes numerous possible applications of Metschnikowia in human life, including potential secondary metabolites in industrial fields such as cosmetics and pharmaceuticals. Furthermore, Metschnikowia-yeast interaction is mentioned as a potential area for further exploration in terms of co-cultured microbes as biocontrol. Since Metschnikowia yeast arose in a variety of ecosystems, more discussion will be held regarding the interactions between Metschnikowia and their surroundings, particularly in fruits. Finally, the current regulatory challenges of Metschnikowia-based products are examined, and future research opportunities on Metschnikowia utilization are presented. Key points • Utilization of Metschnikowia genus in various human aspects. • Promising secondary metabolites produced by Metschnikowia. • Challenge and opportunity on developing Metschnikowia-based products. Graphical Abstract

show abstract

Analysis of microbial communities in local cultivars of astringent persimmon (Diospyros kaki) fruits grown in Gyeongnam Province of Korea

Abstract: Aim :Methodology : Results :Interpretation :

Cited by 4 publications

References 10 publications

The whole-genome sequence of the novel yeast species Metschnikowia persimmonesis isolated from medicinal plant Diospyros kaki Thunb

The whole-genome sequence of the novel yeast species Metschnikowia persimmonesis isolated from medicinal plant Diospyros kaki Thunb

Yeast metabolic engineering for the production of pharmaceutically important secondary metabolites

Unforeseen current and future benefits of uncommon yeast: the Metschnikowia genus

Contact Info

Product

Resources

About